drugset
drugset / Trial / NCT00654043

Bioavailability Study of Torsemide Tablets Under Fed Conditions

NCT00654043 ↗

Phase 1 Completed 24 enrolled Par Pharmaceutical, Inc. Anapharm · collab
Non-randomizedCrossoverOpen-label

Summary

To compare the single-dose bioavailability of Torsemide tablets with Demadex

Timeline

Start
2001-04
Primary completion
2001-05
Completion
2001-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Torsemide Other / unclassified 20 mg —

Indications

No indication recorded.